| __timestamp | Amneal Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 6795238 |
| Thursday, January 1, 2015 | 109679000 | 7454247 |
| Friday, January 1, 2016 | 118757000 | 10345862 |
| Sunday, January 1, 2017 | 109046000 | 16984203 |
| Monday, January 1, 2018 | 230435000 | 16187290 |
| Tuesday, January 1, 2019 | 289598000 | 9299233.54 |
| Wednesday, January 1, 2020 | 326727000 | 19232000 |
| Friday, January 1, 2021 | 365504000 | 23611000 |
| Saturday, January 1, 2022 | 399700000 | 26700000 |
| Sunday, January 1, 2023 | 429675000 | 28215000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Amneal Pharmaceuticals, Inc. and Summit Therapeutics Inc. have showcased contrasting strategies. Amneal's SG&A expenses have surged by over 400% from 2014 to 2023, reflecting its aggressive expansion and market penetration efforts. In contrast, Summit Therapeutics has maintained a more conservative growth, with SG&A expenses increasing by approximately 315% in the same period. This divergence highlights Amneal's focus on scaling operations, while Summit prioritizes efficiency. As of 2023, Amneal's SG&A expenses are nearly 15 times higher than Summit's, underscoring the different paths these companies have taken. Investors and industry analysts should consider these trends when evaluating the operational strategies and future potential of these pharmaceutical giants.
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Catalyst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Evotec SE
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.